Drug Database
VI
vincristine sulfate
✓ ApprovedPierre Fabre S.A. · Small Molecule · Small Molecule
What is vincristine sulfate?
vincristine sulfate is a small molecule developed by Pierre Fabre S.A.. It is approved for therapeutic indications via injectable (others) or intravenous (iv).
Drug Profile
| Company | Pierre Fabre S.A. |
| Drug Class | Small Molecule |
| Route | Injectable (Others), Intravenous (IV) |
| Status | Approved |
Sources: ClinicalTrials.gov, Pierre Fabre S.A.
Therapeutic Indications
vincristine sulfate is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Neoplasm malignant | ✓ Approved |
Related Research Articles
Unable to load articles right now.